• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卟啉病与肾脏疾病。

Porphyria and kidney diseases.

作者信息

Pallet Nicolas, Karras Alexandre, Thervet Eric, Gouya Laurent, Karim Zoubida, Puy Hervé

机构信息

INSERM U1147, Centre Universitaire des Saints Pères, Paris, France.

Université Paris Descartes, Paris, France.

出版信息

Clin Kidney J. 2018 Apr;11(2):191-197. doi: 10.1093/ckj/sfx146. Epub 2018 Jan 10.

DOI:10.1093/ckj/sfx146
PMID:29644058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5888040/
Abstract

The kidneys, after the bone marrow and liver, are third in terms of the amounts of haem synthesized daily. Haem is incorporated into haemoproteins that are critical to renal physiology. In turn, disturbances in haem metabolism interfere with renal physiology and are tightly interrelated with kidney diseases. Acute intermittent porphyria causes kidney injury, whereas medical situations associated with end-stage renal disease, such as porphyrin accumulation, iron overload and hepatitis C, participate in the inhibition of uroporphyrinogen decarboxylase and predispose the individual to porphyria cutanea tarda. Even if some of these interactions have been known for a long time, the clinical situations associated with these interrelations have strikingly evolved over time with the advent of new therapeutic strategies for dialysis therapy and a better understanding of the pathophysiological mechanisms of porphyria-associated kidney disease. Physicians should be aware of these interactions. The aim of this review is to summarize the complex interactions between kidney physiology and pathology in the settings of porphyria and to emphasize their often-underestimated importance.

摘要

就每日合成血红素的量而言,肾脏仅次于骨髓和肝脏,位列第三。血红素被整合到对肾脏生理功能至关重要的血红蛋白中。反过来,血红素代谢紊乱会干扰肾脏生理功能,并与肾脏疾病密切相关。急性间歇性卟啉症会导致肾损伤,而与终末期肾病相关的医学情况,如卟啉蓄积、铁过载和丙型肝炎,会参与抑制尿卟啉原脱羧酶,并使个体易患迟发性皮肤卟啉症。即使其中一些相互作用早已为人所知,但随着透析治疗新策略的出现以及对卟啉相关肾脏疾病病理生理机制的更好理解,与这些相互关系相关的临床情况也随着时间的推移发生了显著变化。医生应该了解这些相互作用。本综述的目的是总结卟啉症背景下肾脏生理与病理之间的复杂相互作用,并强调它们常常被低估的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/5888040/77b1db782806/sfx146f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/5888040/ca169317880e/sfx146f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/5888040/9c61eec3186d/sfx146f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/5888040/77b1db782806/sfx146f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/5888040/ca169317880e/sfx146f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/5888040/9c61eec3186d/sfx146f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/5888040/77b1db782806/sfx146f3.jpg

相似文献

1
Porphyria and kidney diseases.卟啉病与肾脏疾病。
Clin Kidney J. 2018 Apr;11(2):191-197. doi: 10.1093/ckj/sfx146. Epub 2018 Jan 10.
2
Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.迟发性皮肤卟啉症中肝脏尿卟啉原脱羧酶活性降低。
N Engl J Med. 1982 Apr 1;306(13):766-9. doi: 10.1056/NEJM198204013061302.
3
Development of chronic hepatic porphyria (porphyria cutanea tarda) with inherited uroporphyrinogen decarboxylase deficiency under exposure to dioxin.在二噁英暴露情况下,因遗传性尿卟啉原脱羧酶缺乏而发生慢性肝性卟啉病(迟发性皮肤卟啉病)。
Int J Biochem. 1984;16(4):369-73. doi: 10.1016/0020-711x(84)90134-4.
4
Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.家族性和散发性迟发性皮肤卟啉症:临床、生化及遗传学特征,重点关注铁状态
Acta Derm Venereol. 2003;83(2):115-20. doi: 10.1080/00015550310007454.
5
Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.通过测量红细胞尿卟啉原脱羧酶鉴别两种迟发性皮肤卟啉症
Clin Sci (Lond). 1980 Jun;58(6):477-84. doi: 10.1042/cs0580477.
6
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.迟发性皮肤卟啉症中的一种遗传性酶缺陷:尿卟啉原脱羧酶活性降低。
J Clin Invest. 1976 Nov;58(5):1089-97. doi: 10.1172/JCI108560.
7
Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.迟发性皮肤卟啉症及其他形式卟啉症中的红细胞尿卟啉原脱羧酶活性
N Engl J Med. 1978 Nov 16;299(20):1095-8. doi: 10.1056/NEJM197811162992002.
8
Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.丙型肝炎病毒与迟发性皮肤卟啉症:强关联证据
Hepatology. 1992 Dec;16(6):1322-6. doi: 10.1002/hep.1840160603.
9
[Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].[血色素沉着症基因在迟发性皮肤卟啉症中的作用。56例前瞻性研究]
Ann Dermatol Venereol. 2001 May;128(5):600-4.
10
A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.人类尿卟啉原脱羧酶基因突变(G281E)导致肝红细胞生成性卟啉病和显性家族性迟发性皮肤卟啉病:对西班牙患者的生化和遗传学研究
J Invest Dermatol. 1995 Apr;104(4):500-2. doi: 10.1111/1523-1747.ep12605953.

引用本文的文献

1
Increased Mitochondrial Superoxide Level Is Partially Associated With Vemurafenib-Induced Renal Tubular Toxicity.线粒体超氧化物水平升高与维莫非尼诱导的肾小管毒性部分相关。
Basic Clin Pharmacol Toxicol. 2025 Apr;136(4):e70015. doi: 10.1111/bcpt.70015.
2
Patient experience with acute hepatic porphyria before and after long-term givosiran treatment in a qualitative interview study.一项定性访谈研究中急性肝卟啉症患者在长期使用吉沃赛安治疗前后的体验
Mol Genet Metab Rep. 2024 Dec 20;42:101174. doi: 10.1016/j.ymgmr.2024.101174. eCollection 2025 Mar.
3
Porphyria cutanea tarda: a unique iron-related disorder.

本文引用的文献

1
Porphyria.卟啉病
N Engl J Med. 2017 Aug 31;377(9):862-872. doi: 10.1056/NEJMra1608634.
2
Porphyria cutanea tarda: an intriguing genetic disease and marker.迟发性皮肤卟啉症:一种引人入胜的遗传性疾病及标志物。
Int J Dermatol. 2017 Jun;56(6):e106-e117. doi: 10.1111/ijd.13580. Epub 2017 Mar 21.
3
Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments.急性肝性和红细胞生成性卟啉病:从δ-氨基-γ-酮戊酸合酶1和2到新的分子基础与治疗方法
迟发性皮肤卟啉症:一种独特的铁相关疾病。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):450-456. doi: 10.1182/hematology.2024000664.
4
Kidney disease in acute intermittent porphyria: histological features and therapeutic perspectives.急性间歇性卟啉病中的肾脏疾病:组织学特征与治疗前景
J Nephrol. 2024 May;37(4):1165-1169. doi: 10.1007/s40620-023-01828-0. Epub 2024 Apr 20.
5
Causal effect of porphyria biomarkers on alcohol-related hepatocellular carcinoma through Mendelian Randomization.通过孟德尔随机化研究卟啉症生物标志物对酒精性肝细胞癌的因果关系。
PLoS One. 2024 Mar 20;19(3):e0299536. doi: 10.1371/journal.pone.0299536. eCollection 2024.
6
Potential Biomarkers for the Earlier Diagnosis of Kidney and Liver Damage in Acute Intermittent Porphyria.急性间歇性卟啉病中肾脏和肝脏损伤早期诊断的潜在生物标志物
Life (Basel). 2023 Dec 21;14(1):19. doi: 10.3390/life14010019.
7
System for Self-excited Targeted Photodynamic Therapy Based on the Multimodal Protein DARP-NanoLuc-SOPP3.基于多模态蛋白DARP-NanoLuc-SOPP3的自激发靶向光动力治疗系统
Acta Naturae. 2023 Oct-Dec;15(4):100-110. doi: 10.32607/actanaturae.27331.
8
Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.利迪帕韦/索磷布韦作为单独治疗伴有慢性丙型肝炎的迟发性皮肤卟啉症有效。
Dig Dis Sci. 2023 Jun;68(6):2738-2746. doi: 10.1007/s10620-023-07859-8. Epub 2023 Feb 22.
9
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.AGA 临床实践更新:急性肝性血卟啉症的诊断和管理:专家综述。
Gastroenterology. 2023 Mar;164(3):484-491. doi: 10.1053/j.gastro.2022.11.034. Epub 2023 Jan 13.
10
Plasma porphyrins among end stage renal disease patients and cutaneous symptoms- is there still an association?终末期肾病患者的血浆卟啉与皮肤症状——是否仍存在关联?
Mol Genet Metab Rep. 2022 Oct 19;33:100928. doi: 10.1016/j.ymgmr.2022.100928. eCollection 2022 Dec.
Curr Opin Hematol. 2017 May;24(3):198-207. doi: 10.1097/MOH.0000000000000330.
4
A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.肽转运体2的一种变体可预测卟啉症相关肾病的严重程度。
J Am Soc Nephrol. 2017 Jun;28(6):1924-1932. doi: 10.1681/ASN.2016080918. Epub 2016 Dec 28.
5
Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria.卟啉病主要类型的临床、生化及分子特征
Adv Clin Exp Med. 2016 Mar-Apr;25(2):361-8. doi: 10.17219/acem/58955.
6
Porphyrias: A 2015 update.卟啉病:2015年最新进展
Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):412-25. doi: 10.1016/j.clinre.2015.05.009. Epub 2015 Jul 2.
7
High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.急性间歇性血卟啉症患者慢性肾脏病的高患病率和潜在机制。
Kidney Int. 2015 Aug;88(2):386-95. doi: 10.1038/ki.2015.97. Epub 2015 Apr 1.
8
Pro-oxidant effect of ALA is implicated in mitochondrial dysfunction of HepG2 cells.ALA的促氧化作用与HepG2细胞的线粒体功能障碍有关。
Biochimie. 2014 Nov;106:157-66. doi: 10.1016/j.biochi.2014.08.014. Epub 2014 Sep 8.
9
Desferrioxamine treatment of porphyria cutanea tarda in a patient with HIV and chronic renal failure.去铁胺治疗 HIV 合并慢性肾衰竭合并迟发性皮肤卟啉病。
Dermatol Ther. 2014 Jan-Feb;27(1):16-8. doi: 10.1111/dth.12024. Epub 2013 Jun 6.
10
Heme enzyme structure and function.血红素酶的结构与功能。
Chem Rev. 2014 Apr 9;114(7):3919-62. doi: 10.1021/cr400415k. Epub 2014 Jan 8.